Infusion of autologous autologous transplant cord blood. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy37

Fetal Blood Spinal Cord Transplants Umbilical Cord Hematopoietic Stem Cells Cells, Cultured T-Lymphocytes Leukocytes, Mononuclear T-Lymphocytes, Cytotoxic Bone Marrow Cells Dendritic Cells Lymphocytes Stem Cells Killer Cells, Natural Bone Marrow CD4-Positive T-Lymphocytes B-Lymphocytes Blood Cells Clone Cells Monocytes Spermatic Cord Kidney Antilymphocyte Serum Mesenchymal Stromal Cells Platelet-Rich Plasma CD8-Positive T-Lymphocytes T-Lymphocytes, Regulatory Autografts T-Lymphocyte Subsets Fetus Lymphocyte Subsets Lymphocytes, Tumor-Infiltrating Liver Antigen-Presenting Cells Placenta Leukocytes Allografts

Organisms10

Mice, SCID Transplantation Chimera Dogs Mice, Inbred NOD Rats, Sprague-Dawley Cytomegalovirus Rabbits Sheep Herpesvirus 4, Human Mice, Inbred C57BL

Diseases32

Hodgkin Disease Multiple Myeloma Recurrence Spinal Cord Injuries Graft vs Host Disease Hematologic Neoplasms Lymphoma, Non-Hodgkin Postoperative Complications Cytomegalovirus Infections Leukemia Spinal Cord Diseases Acute Disease Disease Models, Animal Spinal Cord Compression Leukemia, Myeloid, Acute Melanoma Neoplasms Lymphoma Hematologic Diseases Spinal Cord Ischemia Cadaver Precursor Cell Lymphoblastic Leukemia-Lymphoma Spinal Cord Neoplasms Kidney Failure, Chronic Opportunistic Infections Infection Anemia, Aplastic Liver Failure Chronic Disease Leukemia, Myeloid Lymphoproliferative Disorders Ischemia

Chemicals and Drugs48

Antigens, CD34 Immunosuppressive Agents Melphalan Cyclophosphamide Antigens, CD HLA Antigens Cyclosporine Carmustine Tacrolimus Antibodies, Monoclonal Etoposide Antigens, Neoplasm Interleukin-2 Thiotepa Granulocyte Colony-Stimulating Factor Busulfan Myeloablative Agonists Cytarabine Cancer Vaccines Interferon-gamma Cytokines Mycophenolic Acid Antilymphocyte Serum Recombinant Proteins Granulocyte-Macrophage Colony-Stimulating Factor Biological Markers Vincristine Immunoglobulin G Antigens, CD3 Antigens, CD45 Isoantigens HLA-DR Antigens Antineoplastic Agents Antigens, CD38 HLA-A Antigens Antineoplastic Agents, Alkylating Prednisone Isoantibodies Stem Cell Factor ADP-ribosyl Cyclase Oxyquinoline Antibodies, Neoplasm Phytohemagglutinins Indium Doxorubicin Membrane Glycoproteins HLA-A2 Antigen RNA, Messenger

Analytical, Diagnostic and Therapeutic Techniques and Equipment93

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Mobilization Blood Transfusion, Autologous Treatment Outcome Infusions, Intravenous Retrospective Studies Survival Analysis Kidney Transplantation Infusions, Parenteral Infusion Pumps Stem Cell Transplantation Combined Modality Therapy Heart Transplantation Infusions, Intra-Arterial Transplantation Histocompatibility Testing Peripheral Blood Stem Cell Transplantation Lymphocyte Activation Antineoplastic Combined Chemotherapy Protocols Lung Transplantation Cell Separation Follow-Up Studies Lymphocyte Culture Test, Mixed Bone Marrow Purging Flow Cytometry Whole-Body Irradiation Immunosuppression Immunophenotyping Cell Transplantation Remission Induction Prospective Studies Survival Rate Colony-Forming Units Assay Cord Blood Stem Cell Transplantation Cell Culture Techniques Disease-Free Survival Fetal Tissue Transplantation Salvage Therapy Immunotherapy, Adoptive Coculture Techniques Blood Cell Count Immunotherapy Blood Preservation Disease Models, Animal Drug Administration Schedule Feasibility Studies Blood Transfusion Risk Factors Prognosis Bone Transplantation Infusion Pumps, Implantable Leukocyte Count Tissue Transplantation Leukapheresis Pilot Projects Mesenchymal Stem Cell Transplantation Cytotoxicity Tests, Immunologic Platelet Count Cryopreservation Transplantation, Heterologous Tissue Engineering Lymphocyte Transfusion Transduction, Genetic Transplantation, Isogeneic Blood Component Removal Blood Pressure Polymerase Chain Reaction Infusions, Subcutaneous Fatal Outcome Immunohistochemistry Cell Count Cohort Studies Cell- and Tissue-Based Therapy Transplantation, Heterotopic Platelet Transfusion Models, Animal Injections, Intravenous Genetic Therapy Biopsy Operative Blood Salvage Multivariate Analysis Analysis of Variance Incidence Brain Tissue Transplantation Heart-Lung Transplantation Tissue and Organ Harvesting Actuarial Analysis Lymphocyte Depletion Drug Evaluation

Phenomena and Processes30

Graft Survival Time Factors Graft Rejection Pregnancy Lymphocyte Activation Cytotoxicity, Immunologic Cell Differentiation Maternal-Fetal Exchange Hematopoiesis Dose-Response Relationship, Drug Histocompatibility Blood Cell Count Transplantation Immunology Leukocyte Count Immunocompromised Host Platelet Count Cell Proliferation Recovery of Function Cell Division Transduction, Genetic Cell Lineage Blood Pressure Cell Count Immunity, Cellular Phenotype Genetic Vectors Immune Tolerance Cell Survival Hemodynamics Regional Blood Flow

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Tissue Engineering

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups4

Infant, Newborn Tissue Donors Living Donors Blood Donors

Health Care22

Treatment Outcome Retrospective Studies Survival Analysis Blood Banks Follow-Up Studies Prospective Studies Survival Rate Disease-Free Survival Tissue and Organ Procurement Feasibility Studies Waiting Lists Risk Factors Directed Tissue Donation Pilot Projects Fatal Outcome Cohort Studies Maternal Exposure Multivariate Analysis Analysis of Variance Incidence Age Factors Actuarial Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Fetal Blood Transplantation Conditioning Hematopoietic Stem Cell Mobilization Hodgkin Disease Multiple Myeloma Recurrence Blood Transfusion, Autologous Treatment Outcome Spinal Cord Infusions, Intravenous Retrospective Studies Survival Analysis Spinal Cord Injuries Kidney Transplantation Infusions, Parenteral Graft Survival Transplants Antigens, CD34 Blood Banks Umbilical Cord Time Factors Infusion Pumps Graft Rejection Stem Cell Transplantation Hematopoietic Stem Cells Immunosuppressive Agents Infant, Newborn Tissue Donors Combined Modality Therapy Cells, Cultured Heart Transplantation Infusions, Intra-Arterial T-Lymphocytes Graft vs Host Disease Melphalan Transplantation Histocompatibility Testing Pregnancy Peripheral Blood Stem Cell Transplantation Lymphocyte Activation Antineoplastic Combined Chemotherapy Protocols Hematologic Neoplasms Lung Transplantation Cytotoxicity, Immunologic Cell Separation Cyclophosphamide Follow-Up Studies Lymphocyte Culture Test, Mixed Lymphoma, Non-Hodgkin Bone Marrow Purging Flow Cytometry Whole-Body Irradiation Immunosuppression Immunophenotyping Cell Transplantation Postoperative Complications Antigens, CD HLA Antigens Cyclosporine Cell Differentiation Leukocytes, Mononuclear T-Lymphocytes, Cytotoxic Remission Induction Carmustine Prospective Studies Bone Marrow Cells Survival Rate Colony-Forming Units Assay Cord Blood Stem Cell Transplantation Cell Culture Techniques Dendritic Cells Disease-Free Survival Maternal-Fetal Exchange Lymphocytes Fetal Tissue Transplantation Tacrolimus Salvage Therapy Antibodies, Monoclonal Cytomegalovirus Infections Mice, SCID Etoposide Tissue and Organ Procurement Hematopoiesis Leukemia Immunotherapy, Adoptive Antigens, Neoplasm Living Donors Coculture Techniques Interleukin-2 Dose-Response Relationship, Drug Stem Cells Histocompatibility Blood Cell Count Spinal Cord Diseases Acute Disease Thiotepa

No FAQ available that match "infusion of autologous autologous transplant cord blood"